Renibus Buys Tricida's Kidney Drug Veverimer In Ch. 11 Sale
Law 360 M&A
FEBRUARY 21, 2023
Texas clinical-stage biotechnology company Renibus Therapeutics Inc. will take over the development of Tricida Inc.'s s drug candidate for chronic kidney disease and could eventually pay the bankrupt San Francisco-based company up to $152.75
Let's personalize your content